Neuroprotective Efficacy of Betulinic Acid Hydroxamate, a B55 α/PP2A Activator, in Acute Hypoxia–Ischemia-Induced Brain Damage in Newborn Rats
In conclusion, BAH appears as an effective neuroprotective treatment for neonatal HIBD in a manner associated with the modulation of ex citotoxicity, oxidative stress, and inflammation, showing a broad therapeutic window.
Source: Translational Stroke Research - Category: Neurology Source Type: research
More News: Brain | Ischemic Stroke | MRI Scan | Neurology | Perinatology & Neonatology | Stroke | Study